Health insurance price of chemically modified Plavix to be determined

Published: 2008-04-30 07:00:00

Updated: 2008-04-30 07:00:00

The Health Insurance Review Agency is now under negotiation to determine the insurance price of Daewoong’s Vixgrel, one of chemically modified Plavix (clopidogrel bisulfate), which have drawn keen interest from other five pharmaceutical firms, according to pharmaceutical business sources.

The ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK